郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

肿瘤模型Novel Pyrrolo[3,2-d]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy.

期刊：Molecular cancer therapeutics发表年份：2019作者：Aamod S Dekhne; Khushbu Shah; Gregory S Ducker; Jade M Katinas; Jennifer Wong-Roushar; Md Junayed Nayeen; Arpit Doshi; Changwen Ning; Xun Bao; Josephine Frühauf; Jenney Liu; Adrianne Wallace-Povirk; Carrie O'Connor; Sijana H Dzinic; Kathryn White; Ju
阅读更多 →

肿瘤模型Chlorambucil targets BRCA1/2-deficient tumours and counteracts PARP inhibitor resistance.

期刊：EMBO molecular medicine发表年份：2019作者：Eliana Mc Tacconi; Sophie Badie; Giuliana De Gregoriis; Timo Reisländer; Xianning Lai; Manuela Porru; Cecilia Folio; John Moore; Arnaud Kopp; Júlia Baguña Torres; Deborah Sneddon; Marcus Green; Simon Dedic; Jonathan W Lee; Ankita Sati Batra; Oscar M
阅读更多 →

肿瘤模型Design, Synthesis and Evaluation of New Indolylpyrimidylpiperazines for Gastrointestinal Cancer Therapy.

期刊：Molecules (Basel, Switzerland)发表年份：2019作者：Aaron Tan; Maria V Babak; Gopalakrishnan Venkatesan; Clarissa Lim; Karl-Norbert Klotz; Deron Raymond Herr; Siew Lee Cheong; Stephanie Federico; Giampiero Spalluto; Wei-Yi Ong; Yu Zong Chen; Jason Siau Ee Loo; Giorgia Pastorin
阅读更多 →

肿瘤模型Structural insight into a matured humanized monoclonal antibody HuA21 against HER2-overexpressing cancer cells.

期刊：Acta crystallographica. Section D, Structural biology发表年份：2019作者：Zhenyi Wang; Liansheng Cheng; Gongrui Guo; Baoyun Cheng; Siyi Hu; Hongmin Zhang; Zhongliang Zhu; Liwen Niu
阅读更多 →